Cargando…
Cortisol as a Biomarker of Mental Disorder Severity
Cortisol—the most important steroid hormone with a significant effect on body metabolism—strongly affects peripheral tissues and the central nervous system. Fluctuations in cortisol secretion often accompany psychiatric disorders, and normalization of its levels correlates with improvement in the pa...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584322/ https://www.ncbi.nlm.nih.gov/pubmed/34768724 http://dx.doi.org/10.3390/jcm10215204 |
_version_ | 1784597421243760640 |
---|---|
author | Dziurkowska, Ewelina Wesolowski, Marek |
author_facet | Dziurkowska, Ewelina Wesolowski, Marek |
author_sort | Dziurkowska, Ewelina |
collection | PubMed |
description | Cortisol—the most important steroid hormone with a significant effect on body metabolism—strongly affects peripheral tissues and the central nervous system. Fluctuations in cortisol secretion often accompany psychiatric disorders, and normalization of its levels correlates with improvement in the patient’s health. This indicates that cortisol may be useful as a biological marker that can help determine the likelihood of mental illness, its impending onset, and the severity of symptoms, which is especially important in the face of the increasing prevalence of mental disorders, including those associated with social isolation and anxiety during the COVID-19 pandemic. This publication reviews recent reports on cortisol levels in healthy participants and shows the current state of knowledge on changes in the levels of this hormone in people at risk for depression, bipolar disorder, and psychosis. It shows how people with psychiatric disorders react to stressful situations and how the applied therapies affect cortisol secretion. The influence of antidepressants and antipsychotics on cortisol levels in healthy people and those with mental disorders is also described. Finally, it reviews publications on the patterns of cortisol secretion in patients in remission. |
format | Online Article Text |
id | pubmed-8584322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85843222021-11-12 Cortisol as a Biomarker of Mental Disorder Severity Dziurkowska, Ewelina Wesolowski, Marek J Clin Med Review Cortisol—the most important steroid hormone with a significant effect on body metabolism—strongly affects peripheral tissues and the central nervous system. Fluctuations in cortisol secretion often accompany psychiatric disorders, and normalization of its levels correlates with improvement in the patient’s health. This indicates that cortisol may be useful as a biological marker that can help determine the likelihood of mental illness, its impending onset, and the severity of symptoms, which is especially important in the face of the increasing prevalence of mental disorders, including those associated with social isolation and anxiety during the COVID-19 pandemic. This publication reviews recent reports on cortisol levels in healthy participants and shows the current state of knowledge on changes in the levels of this hormone in people at risk for depression, bipolar disorder, and psychosis. It shows how people with psychiatric disorders react to stressful situations and how the applied therapies affect cortisol secretion. The influence of antidepressants and antipsychotics on cortisol levels in healthy people and those with mental disorders is also described. Finally, it reviews publications on the patterns of cortisol secretion in patients in remission. MDPI 2021-11-08 /pmc/articles/PMC8584322/ /pubmed/34768724 http://dx.doi.org/10.3390/jcm10215204 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Dziurkowska, Ewelina Wesolowski, Marek Cortisol as a Biomarker of Mental Disorder Severity |
title | Cortisol as a Biomarker of Mental Disorder Severity |
title_full | Cortisol as a Biomarker of Mental Disorder Severity |
title_fullStr | Cortisol as a Biomarker of Mental Disorder Severity |
title_full_unstemmed | Cortisol as a Biomarker of Mental Disorder Severity |
title_short | Cortisol as a Biomarker of Mental Disorder Severity |
title_sort | cortisol as a biomarker of mental disorder severity |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584322/ https://www.ncbi.nlm.nih.gov/pubmed/34768724 http://dx.doi.org/10.3390/jcm10215204 |
work_keys_str_mv | AT dziurkowskaewelina cortisolasabiomarkerofmentaldisorderseverity AT wesolowskimarek cortisolasabiomarkerofmentaldisorderseverity |